Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm

Lung Cancer - Tập 172 - Trang 108-116 - 2022
Georgios Stamatis1, Gunda Leschber2, Birte Schwarz1, Diana Lütke Brintrup3, Sarah Flossdorf3, Bernward Passlick4, Erich Hecker5, Christian Kugler6, Martin Eichhorn7, Thomas Krbek8, Stephan Eggeling9, Rudolf Hatz10, Michael Rolf Müller11, Sven Hillinger12, Clemens Aigner1, Karl-Heinz Jöckel3
1Thoracic Surgery and Endoscopy, University Medicine Essen- Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany
2Departement of Thoracic Surgery, Evangelische Lungenklinik ELK Chest Hospital, Berlin, Germany
3Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University of Duisburg-Essen, Essen, Germany
4Departement of Thoracic Surgery, University Freiburg, Germany
5Departement of Thoracic Surgery, Evangelisches Krankenhaus Herne, Germany
6Departement of Thoracic Surgery, LungenClinic Grosshansdorf, Germany
7Departement of Thoracic Surgery, Heidelberg University, Germany
8Departement of Thoracic Surgery, Krankenhaus Bethanien Moers, Germany
9Departement of Thoracic Surgery, Vivantes Klinikum Neukölln, Berlin, Germany
10Departement of Thoracic Surgery, Asklepios Fachkliniken München-Gauting, Germany
11Departement of Thoracic Surgery, Krankenhaus Nord/Klinik Floridsdorf, Wien, Austria
12Departement of Thoracic Surgery, Universitätsspital Zürich, Switzerland

Tài liệu tham khảo

Brunelli, 2009, European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. “ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)”, Eur. Respir. J., 34, 17, 10.1183/09031936.00184308 Farjah, 2008, Temporal trends in the management of potentially resectable lung cancer, Ann. Thorac. Surg., 85, 1850, 10.1016/j.athoracsur.2007.12.081 Okada, 2003, Characteristics and prognosis of patients after resection of non-small cell lung carcinoma measuring 2 cm or less in greatest dimension, Cancer, 98, 535, 10.1002/cncr.11530 Janssen-Heijnen, 2007, Prognosis for long-term survivors of cancer, Ann. Onc., 18, 1408, 10.1093/annonc/mdm127 Koike, 2003, Intentional limited pulmonary resection for peripheral T1N0M0 small – sized lung cancer, J. Thorac. Cardiovasc. Surg., 125, 924, 10.1067/mtc.2003.156 Tsubota, 1998, Ongoing prospective study of segmentectomy for small lung tumor, Ann. Thorac. Surg., 66, 1787, 10.1016/S0003-4975(98)00819-4 Okada, 2006, Radical sublobar resection for small-sized non-small cell lung cancer: A multicenter study, J. Thorac. Cardiovasc. Surg., 132, 769, 10.1016/j.jtcvs.2006.02.063 Ginsberg, 1995, Randomised trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group, Ann. Thorac. Surg., 60, 615, 10.1016/0003-4975(95)00537-U Altorki, 2018, Perioperative mortality and morbidity after sublobar versus lobar resection for early stage non-small celllung cancer: post-hoc analysis of an international, randomized, phase 3 trial (CALGB/Alliance 140503), Lancet Respir. Med., 6, 915, 10.1016/S2213-2600(18)30411-9 Suzuki, 2019, Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial, J. Thorac. Cardiovasc. Surg., 158, 895, 10.1016/j.jtcvs.2019.03.090 Stamatis, 2019, Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA, Lung Cancer, 138, 19, 10.1016/j.lungcan.2019.09.021 Jemal, 2007, Cancer statistics, 2007, CA Cancer J. Clin., 57, 43, 10.3322/canjclin.57.1.43 Henschke, 2006, International Early Lung Cancer Action Program Inverstigators. OS Survival of patients with stage I lung cancer detected on CT screening, N. Engl. J. Med., 355, 1763, 10.1056/NEJMoa060476 Goeckenjan, 2010, Prävention, Diagnostik, Therapie, und Nachsorge des Lungenkarzinoms. Interdisziplinäre S3 Leitlinie, Pneumologie, 64, S23 Nakamura, 2005, Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis, Br. J. Cancer, 92, 1033, 10.1038/sj.bjc.6602414 Port, 2003, Tumor size predicts survival within stage IA non-small cell lung cancer, Chest, 124, 1828, 10.1378/chest.124.5.1828 F.C. Detterbeck, The eight edition TNM stage classification for lung cancer: What does it mean on main street, J. Thorac. Cardiovasc. Surg. 155 (2018) 356-359. Matsumura, 2012, Reasonable extent of lymph node dissection in intentional segmentectomy for small-sized peripheral non-cell lung cancer: from the clinicopathological findings of patients who underwent lobectomy with systematic lymph node dissection, J. Thorac. Oncol., 7, 1691, 10.1097/JTO.0b013e31826912b4 Darling, 2011, Randomized trial of mediastinal lymph node sampling vesrus complete lymphadenectomy during pulmonary resection in the patients with N0 or N1 (less than hilar) non-small cell carcinoma. Results of the American College of Surgeons Oncology Group Z0030 trial, J. Thorac. Cardiovasc. Surg., 141, 662, 10.1016/j.jtcvs.2010.11.008 Wu, 2020, Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis, World J. Surg. Oncol., 18, 10.1186/s12957-020-02090-5 Qu, 2017, Long-term outcomes of stage I NSCLC (≤3cm) patients following segmentectomy are equivalent to lobectomy under analogous exent of lymph node removal: a PSM based analysis, J. Thorac. Dis., 9, 4561, 10.21037/jtd.2017.10.129 Mattioli, 2011, Does anatomical segmenectomy allow an adequate lymph node staging for cT1a non-small cell lung cancer?, J. Thorac. Oncol., 6, 1537, 10.1097/JTO.0b013e3182209063 Osarogiagbon, 2014, Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node negative non-small cell lung cancer, Ann. Thorac. Surg., 97, 385, 10.1016/j.athoracsur.2013.09.058 Becker, 2018, Influence of extent of lymph node evaluation on survival for pathologically lymph node negative non-small cell lung cancer, Am. J. Clin. Oncol., 41, 820, 10.1097/COC.0000000000000379 De Leyn, 2007, ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer, Eur. J. Cardiothorac. Surg., 32, 1, 10.1016/j.ejcts.2007.01.075 Sienel, 2008, Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections, Eur. J. Cardiovasc. Surg., 33, 728, 10.1016/j.ejcts.2007.12.048 El-Sherif, 2007, Margin and local recurrence after sublobar resection of NSCLC, Ann. Surg. Oncol., 14, 2400, 10.1245/s10434-007-9421-9 Sawabata, 2004, Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study, Ann. Thorac. Surg., 77, 415, 10.1016/S0003-4975(03)01511-X Schuchert, 2007, Anatomic Segmentectomy in the Treatment of Stage I NSCLC, Ann. Thorac. Surg., 84, 926, 10.1016/j.athoracsur.2007.05.007 Kodama, 1997, Intentional Limited Resection for Selected Patients with T1N0M0 Non-Small Cell Lung Cancer. A Single_Institution Study, J. Thorac. Cardiovasc. Surg., 114, 347, 10.1016/S0022-5223(97)70179-X Khullar, 2015, Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer: an analysis from the national cancer data base, J. Thorac. Oncol., 10, 1625, 10.1097/JTO.0000000000000664 Landreneau, 2014, Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small cell lung cancer: A propensity-matched analysis, J. Clin. Oncol., 32, 2449, 10.1200/JCO.2013.50.8762 Cao, 2015, Could less be more? A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patienst selection, Lung Cancer, 89, 121, 10.1016/j.lungcan.2015.05.010 Hattori, 2012, Is limited resection appropriate for radiologically “solid” tumors in small lung cancers?, Ann. Thorac Surg., 94, 212, 10.1016/j.athoracsur.2012.03.033 Tsutani, 2014, Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma, Chest, 145, 66, 10.1378/chest.13-1094